Drug · DIN 02411393
ILEVRO
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 21, 2018; first marketed June 1, 2014.
- Drug Identification Number (DIN)
- 02411393
- Company (DIN owner)
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Suspension
- Route
- Ophthalmic
- Therapeutic class (ATC)
- Nepafenac S01BC10
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| NEPAFENAC | 0.3 % | W/V |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 10, 2017: NOC 18964New Drug Submission (NDS) · Transfer of drug identification number
- August 22, 2013: NOC 14681New Drug Submission (NDS)